Rare 'Pirate Disease' Linked to Popular Weight-Loss Drugs

New research suggests GLP-1 medications may increase risk of vitamin deficiencies if diet is not closely monitored.

Published on Feb. 21, 2026

Got story updates? Submit your updates here. ›

A new systematic review from the Hunter Medical Research Institute in Australia has found that popular GLP-1 weight-loss medications, while effective for shedding pounds, may also increase the risk of rare vitamin deficiencies like scurvy if patients' diets are not closely monitored. Researchers say clinical trials often fail to track changes in users' eating habits and nutrient intake, which could lead to issues like anemia, loose teeth, and slow wound healing over time.

Why it matters

This research highlights a potential blind spot in the current understanding of how GLP-1 medications impact overall health and nutrition. While the drugs have helped millions lose weight, the findings suggest doctors and patients may need to be more vigilant about ensuring adequate vitamin and mineral intake to avoid serious deficiency-related complications.

The details

The review found that while GLP-1 drugs effectively suppress appetite, they may also inadvertently lead to nutrient deficiencies if users don't maintain a nutritionally-dense diet. One key concern is the potential for scurvy, a rare disease caused by a lack of vitamin C that was historically known as 'pirate's disease.' Other deficiencies like iron and B vitamins could also pose risks. Researchers note these complications remain uncommon, but the symptoms can be difficult to distinguish from common side effects of the medications.

  • The systematic review was published on February 21, 2026.

The players

Hunter Medical Research Institute

An Australian research institute that conducted the systematic review on the potential nutritional risks of GLP-1 weight-loss medications.

Got photos? Submit your photos here. ›

What’s next

Researchers are calling for doctors to more closely monitor patients' diets and nutrient levels when prescribing GLP-1 medications, as well as for future clinical trials to include detailed assessments of users' eating habits and nutritional status.

The takeaway

While GLP-1 drugs have proven effective for weight loss, this new research suggests they may also carry a risk of rare but serious vitamin deficiencies if patients' overall nutrition is not carefully managed. Doctors and patients will need to be vigilant about maintaining a balanced, nutrient-dense diet to ensure long-term health and wellbeing.